Liver transplantation to treat familial amyloidotic polyneuropathy (FAP) and clinical chemistry

Japanese Journal of Clinical Chemistry

Volumn 37, Issue 2, 2008, Pages 141-147

  Obayashi, Konen ^a   Ando, Yukio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL CHEMISTRY; FAMILIAL AMYLOID POLYNEUROPATHY; LIVER TRANSPLANTATION;

EID: 44349131577     PISSN: 03705633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, Andersen O, Karlberg I, Nordén G, Nakazato M, Hawkins P, Richardson S, Pepys MB:Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30) . Clin Genet, 40: 242-246, 1991.
2. Matsunami H, Makuuchi M, Kawasaki S, Hashikura Y, Ikegami T, Nakazawa Y, Miyagawa S, Takei Y, Ikeda S, Yanagisawa N: A case of familial amyloid polyneuropathy treated with partial liver transplantation using a graft from a living related donor. Transplantation, 60: 301-303, 1995.
3. Ando Y, Tashima K, Tanaka Y, Nakazato M, Ericzon BG, Duraj FF, Sakashita N, Kimura E, Ando E, Yonehara T, Yamashita T, Nakamura M, Uchino M, Ando M: Treatment of a Japanese patient with familial amyloidotic polyneuropathy with orthotopic liver transplantation. Intern Med, 33: 730-732, 1994.
4. Suhr O, Danielsson A, Holmgren G, Steen L: Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med, 235: 479-485, 1994.
5. Tashima K, Ando Y, Tanaka Y, Ando E, Ando M, Uchino M: Heterogeneity of clinical symptoms in patients with familial amyloidotic polyneuropathy (FAP) (Met30) . Amyloid, 4: 108-111, 1997.
6. Tashima K, Ando Y, Terazaki H, Yoshimatsu S, Suhr OB, Obayashi K, Yamashita T, Ando E, Uchino M, Ando M: Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients. J Neurol Sci, 171: 19-23, 1999.
7. Haraoka K, Ando Y, Ando E, Sun X, Nakamura M, Terazaki H, Misumi S, Tanoue Y, Tajiri T, Shoji S, Ishizaki T, Okabe H, Tanihara H: Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid, 9: 247-251, 2002.
8. Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y: A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation, 77: 345-359, 2004.
9. Sousa MM, Ferrão J, Fernandes R, Guimarães A, Geraldes JB, Perdigoto R, Tomé L, Mota O, Negrão L, Furtado AL, Saraiva MJ: Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers. Lab Invest, 84: 865-873, 2004.
10. Stangou AJ, Heaton ND, Hawkins PN: Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med, 352: 2356, 2005.
11. Goto T, Yamashita T, Ueda M, Ohshima S, Yoneyama K, Nakamura M, Nanjo H, Asonuma K, Inomata Y, Watanabe S, Uchino M, Tanaka K, Ando Y: Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation. Am J Transplant, 6: 2512-2515, 2006.
12. Liu LU, Bodian CA, Gondolesi GE, Schwartz ME, Emre S, Roayaie S, Schiano TD: Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation, 80: 1072-1080, 2005.
13. Li XK, Kita Y, Tamura A, Enosawa S, Amemiya H, Suzuki S: Activation of Fas and perforin pathways in rat liver allograft rejection. Transplant Proc, 30: 19-21, 1998.
14. Krams SM, Villanueva JC, Quinn MB, Martinez OM.: Expression of the cytotoxic T cell mediator granzyme B during liver allograft rejection. Transpl Immunol, 3: 162-166, 1995.
15. Tannapfel A, Kohlhaw K, Ebelt J, Hauss J, Liebert U, Berr F, Wittekind C: Apoptosis and the expression of Fas and Fas ligand (FasL) antigen in rejection and reinfection in liver allograft specimens. Transplantation, 67: 1079-1083, 1999.
16. el-Wahsh M, Fuller BJ, Sreekumar NS, Burroughs AK, Dhillon PA, Rolles K, Davidson BR: Correlation of ICAM-1 expression with postoperative acute cellular rejection in human liver allograft. Biochem Soc Trans, 25; 500S, 1997.
17. Japanese source
18. Fábrega E, Unzueta MG, Cobo M, Casafont F, Amado JA, Romero FP: Value of soluble CD30 in liver transplantation. Transplant Proc, 39: 2295-2296, 2007.
19. Japanese source
20. Zeledon R ME, Ando Y, Asonuma K, Nakamura M, Sun X, Ueda M, Fujii J, Inomata Y: Effect of tacrolimus and partial hepatectomy on transthyretin metabolism in rats. Transpl Int, 19: 233-238, 2006.
21. Ando Y, Terazaki H, Haraoka K, Tajiri T, Nakamura M, Obayashi K, Misumi S, Shoji S, Hata K, Nakagawa K, Ishizaki T, Uemoto S, Inomata Y, Tanaka K, Okabe H: Presence of autoantibody against ATTR Val30Met after sequential liver transplantation. Transplantation, 73: 751-755, 2002.
22. Dubray SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH: Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation, 64: 74-80, 1997.
23. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R: Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation, 66: 229-233, 1998.
24. García-Herola A, Prieto M, Pascual S, Berenguer M, López-Viedma B, Mir J, Vilchez JJ, Berenguer J: Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl Surg, 5: 246-248, 1999.
25. Olofsson BO, Backman C, Karp K, Suhr OB: Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation, 73: 745-751, 2002.
26. Hörnsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB: Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation, 78: 1112-1116, 2004.
27. Westermark P, Sletten K, Johansson B, Cornwell GG 3rd: Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA, 87: 2843-2845, 1990.
28. Liepnieks JJ, Benson MD: Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid, 14: 277-282, 2007.
29. Suhr OB, Anan I, Backman C, Karlsson A, Lindqvist P, Mörner S, Waldenstrom A: Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis ? J Intern Med, 63: 294-301, 2008.